nodes	percent_of_prediction	percent_of_DWPC	metapath
Miglustat—GBA2—saliva-secreting gland—thyroid cancer	0.0792	0.179	CbGeAlD
Miglustat—GBA2—trachea—thyroid cancer	0.0611	0.138	CbGeAlD
Miglustat—UGCG—trachea—thyroid cancer	0.0603	0.136	CbGeAlD
Miglustat—GBA2—thyroid gland—thyroid cancer	0.0484	0.11	CbGeAlD
Miglustat—UGCG—thyroid gland—thyroid cancer	0.0477	0.108	CbGeAlD
Miglustat—GBA2—head—thyroid cancer	0.0429	0.0972	CbGeAlD
Miglustat—UGCG—head—thyroid cancer	0.0423	0.0958	CbGeAlD
Miglustat—Musculoskeletal disorder—Vandetanib—thyroid cancer	0.0397	0.0798	CcSEcCtD
Miglustat—GBA2—lymph node—thyroid cancer	0.03	0.068	CbGeAlD
Miglustat—UGCG—lymph node—thyroid cancer	0.0296	0.0671	CbGeAlD
Miglustat—Polyneuropathy—Epirubicin—thyroid cancer	0.0108	0.0218	CcSEcCtD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—TERT—thyroid cancer	0.0106	0.172	CbGpPWpGaD
Miglustat—Polyneuropathy—Doxorubicin—thyroid cancer	0.01	0.0202	CcSEcCtD
Miglustat—Influenza like illness—Sorafenib—thyroid cancer	0.00928	0.0187	CcSEcCtD
Miglustat—Neuropathy—Sorafenib—thyroid cancer	0.00897	0.018	CcSEcCtD
Miglustat—Weight decreased—Vandetanib—thyroid cancer	0.00804	0.0162	CcSEcCtD
Miglustat—Depression—Vandetanib—thyroid cancer	0.0079	0.0159	CcSEcCtD
Miglustat—Haemoglobin—Vandetanib—thyroid cancer	0.00715	0.0144	CcSEcCtD
Miglustat—Haemorrhage—Vandetanib—thyroid cancer	0.00711	0.0143	CcSEcCtD
Miglustat—Pain in extremity—Sorafenib—thyroid cancer	0.00694	0.014	CcSEcCtD
Miglustat—Visual impairment—Vandetanib—thyroid cancer	0.00686	0.0138	CcSEcCtD
Miglustat—Eye disorder—Vandetanib—thyroid cancer	0.00665	0.0134	CcSEcCtD
Miglustat—Abdominal pain upper—Sorafenib—thyroid cancer	0.00634	0.0127	CcSEcCtD
Miglustat—Mental disorder—Vandetanib—thyroid cancer	0.00623	0.0125	CcSEcCtD
Miglustat—Malnutrition—Vandetanib—thyroid cancer	0.00619	0.0125	CcSEcCtD
Miglustat—Muscle spasms—Vandetanib—thyroid cancer	0.00595	0.012	CcSEcCtD
Miglustat—Tremor—Vandetanib—thyroid cancer	0.0058	0.0117	CcSEcCtD
Miglustat—Weight decreased—Sorafenib—thyroid cancer	0.00542	0.0109	CcSEcCtD
Miglustat—Convulsion—Vandetanib—thyroid cancer	0.00537	0.0108	CcSEcCtD
Miglustat—Neuropathy peripheral—Sorafenib—thyroid cancer	0.00524	0.0105	CcSEcCtD
Miglustat—Dry mouth—Vandetanib—thyroid cancer	0.00516	0.0104	CcSEcCtD
Miglustat—Nervous system disorder—Vandetanib—thyroid cancer	0.00496	0.00997	CcSEcCtD
Miglustat—Thrombocytopenia—Vandetanib—thyroid cancer	0.00495	0.00995	CcSEcCtD
Miglustat—Haemoglobin—Sorafenib—thyroid cancer	0.00482	0.0097	CcSEcCtD
Miglustat—Haemorrhage—Sorafenib—thyroid cancer	0.0048	0.00965	CcSEcCtD
Miglustat—Neuritis—Epirubicin—thyroid cancer	0.00473	0.00951	CcSEcCtD
Miglustat—Connective tissue disorder—Sorafenib—thyroid cancer	0.00472	0.00948	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.00462	0.0754	CbGpPWpGaD
Miglustat—Insomnia—Vandetanib—thyroid cancer	0.00457	0.00919	CcSEcCtD
Miglustat—Paraesthesia—Vandetanib—thyroid cancer	0.00454	0.00913	CcSEcCtD
Miglustat—Dyspepsia—Vandetanib—thyroid cancer	0.00445	0.00895	CcSEcCtD
Miglustat—Decreased appetite—Vandetanib—thyroid cancer	0.00439	0.00884	CcSEcCtD
Miglustat—Neuritis—Doxorubicin—thyroid cancer	0.00438	0.0088	CcSEcCtD
Miglustat—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00436	0.00878	CcSEcCtD
Miglustat—Fatigue—Vandetanib—thyroid cancer	0.00436	0.00876	CcSEcCtD
Miglustat—Pain—Vandetanib—thyroid cancer	0.00432	0.00869	CcSEcCtD
Miglustat—Constipation—Vandetanib—thyroid cancer	0.00432	0.00869	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.00423	0.0689	CbGpPWpGaD
Miglustat—Mental disorder—Sorafenib—thyroid cancer	0.0042	0.00846	CcSEcCtD
Miglustat—Malnutrition—Sorafenib—thyroid cancer	0.00418	0.0084	CcSEcCtD
Miglustat—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00413	0.00831	CcSEcCtD
Miglustat—Muscle spasms—Sorafenib—thyroid cancer	0.00402	0.00808	CcSEcCtD
Miglustat—Abdominal pain—Vandetanib—thyroid cancer	0.004	0.00804	CcSEcCtD
Miglustat—Asthenia—Vandetanib—thyroid cancer	0.00363	0.00729	CcSEcCtD
Miglustat—Gait disturbance—Epirubicin—thyroid cancer	0.00362	0.00728	CcSEcCtD
Miglustat—Dry mouth—Sorafenib—thyroid cancer	0.00348	0.007	CcSEcCtD
Miglustat—Diarrhoea—Vandetanib—thyroid cancer	0.00346	0.00696	CcSEcCtD
Miglustat—Influenza like illness—Epirubicin—thyroid cancer	0.00343	0.0069	CcSEcCtD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—AKT1—thyroid cancer	0.00339	0.0553	CbGpPWpGaD
Miglustat—Gait disturbance—Doxorubicin—thyroid cancer	0.00335	0.00673	CcSEcCtD
Miglustat—Nervous system disorder—Sorafenib—thyroid cancer	0.00334	0.00672	CcSEcCtD
Miglustat—Dizziness—Vandetanib—thyroid cancer	0.00334	0.00672	CcSEcCtD
Miglustat—Thrombocytopenia—Sorafenib—thyroid cancer	0.00334	0.00671	CcSEcCtD
Miglustat—Neuropathy—Epirubicin—thyroid cancer	0.00332	0.00667	CcSEcCtD
Miglustat—Anorexia—Sorafenib—thyroid cancer	0.00325	0.00654	CcSEcCtD
Miglustat—Cramps of lower extremities—Epirubicin—thyroid cancer	0.00324	0.00653	CcSEcCtD
Miglustat—Vomiting—Vandetanib—thyroid cancer	0.00321	0.00646	CcSEcCtD
Miglustat—GBA2—Metabolism—MINPP1—thyroid cancer	0.0032	0.0521	CbGpPWpGaD
Miglustat—Influenza like illness—Doxorubicin—thyroid cancer	0.00317	0.00638	CcSEcCtD
Miglustat—Headache—Vandetanib—thyroid cancer	0.00317	0.00637	CcSEcCtD
Miglustat—Neuropathy—Doxorubicin—thyroid cancer	0.00307	0.00617	CcSEcCtD
Miglustat—Nausea—Vandetanib—thyroid cancer	0.003	0.00604	CcSEcCtD
Miglustat—Cramps of lower extremities—Doxorubicin—thyroid cancer	0.003	0.00604	CcSEcCtD
Miglustat—Dyspepsia—Sorafenib—thyroid cancer	0.003	0.00604	CcSEcCtD
Miglustat—Decreased appetite—Sorafenib—thyroid cancer	0.00296	0.00596	CcSEcCtD
Miglustat—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00294	0.00592	CcSEcCtD
Miglustat—Fatigue—Sorafenib—thyroid cancer	0.00294	0.00591	CcSEcCtD
Miglustat—UGCG—Metabolism—MINPP1—thyroid cancer	0.00292	0.0476	CbGpPWpGaD
Miglustat—Constipation—Sorafenib—thyroid cancer	0.00292	0.00586	CcSEcCtD
Miglustat—Pain—Sorafenib—thyroid cancer	0.00292	0.00586	CcSEcCtD
Miglustat—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00279	0.00561	CcSEcCtD
Miglustat—GBA2—Metabolism—NDUFA13—thyroid cancer	0.00272	0.0443	CbGpPWpGaD
Miglustat—Abdominal pain—Sorafenib—thyroid cancer	0.0027	0.00542	CcSEcCtD
Miglustat—Pain in extremity—Epirubicin—thyroid cancer	0.00256	0.00516	CcSEcCtD
Miglustat—GBA2—Metabolism—CHST14—thyroid cancer	0.00255	0.0416	CbGpPWpGaD
Miglustat—Migraine—Epirubicin—thyroid cancer	0.00252	0.00508	CcSEcCtD
Miglustat—UGCG—Metabolism—NDUFA13—thyroid cancer	0.00248	0.0405	CbGpPWpGaD
Miglustat—Asthenia—Sorafenib—thyroid cancer	0.00245	0.00492	CcSEcCtD
Miglustat—Ataxia—Epirubicin—thyroid cancer	0.00241	0.00485	CcSEcCtD
Miglustat—Pain in extremity—Doxorubicin—thyroid cancer	0.00237	0.00477	CcSEcCtD
Miglustat—Abdominal pain upper—Epirubicin—thyroid cancer	0.00234	0.00471	CcSEcCtD
Miglustat—UGCG—Metabolism—CHST14—thyroid cancer	0.00234	0.0381	CbGpPWpGaD
Miglustat—Migraine—Doxorubicin—thyroid cancer	0.00233	0.0047	CcSEcCtD
Miglustat—Diarrhoea—Sorafenib—thyroid cancer	0.00233	0.00469	CcSEcCtD
Miglustat—Muscular weakness—Epirubicin—thyroid cancer	0.00226	0.00455	CcSEcCtD
Miglustat—Dizziness—Sorafenib—thyroid cancer	0.00225	0.00453	CcSEcCtD
Miglustat—Abdominal distension—Epirubicin—thyroid cancer	0.00223	0.00449	CcSEcCtD
Miglustat—Ataxia—Doxorubicin—thyroid cancer	0.00223	0.00449	CcSEcCtD
Miglustat—Vomiting—Sorafenib—thyroid cancer	0.00217	0.00436	CcSEcCtD
Miglustat—Abdominal pain upper—Doxorubicin—thyroid cancer	0.00217	0.00436	CcSEcCtD
Miglustat—Headache—Sorafenib—thyroid cancer	0.00214	0.0043	CcSEcCtD
Miglustat—Muscular weakness—Doxorubicin—thyroid cancer	0.00209	0.00421	CcSEcCtD
Miglustat—Abdominal distension—Doxorubicin—thyroid cancer	0.00206	0.00415	CcSEcCtD
Miglustat—GBA2—Metabolism—HPGD—thyroid cancer	0.00206	0.0336	CbGpPWpGaD
Miglustat—Nausea—Sorafenib—thyroid cancer	0.00203	0.00407	CcSEcCtD
Miglustat—Weight decreased—Epirubicin—thyroid cancer	0.002	0.00403	CcSEcCtD
Miglustat—Neuropathy peripheral—Epirubicin—thyroid cancer	0.00194	0.00389	CcSEcCtD
Miglustat—UGCG—Metabolism—HPGD—thyroid cancer	0.00188	0.0307	CbGpPWpGaD
Miglustat—Weight decreased—Doxorubicin—thyroid cancer	0.00185	0.00373	CcSEcCtD
Miglustat—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.00179	0.0036	CcSEcCtD
Miglustat—Haemoglobin—Epirubicin—thyroid cancer	0.00178	0.00359	CcSEcCtD
Miglustat—Haemorrhage—Epirubicin—thyroid cancer	0.00177	0.00357	CcSEcCtD
Miglustat—Hypoaesthesia—Epirubicin—thyroid cancer	0.00176	0.00355	CcSEcCtD
Miglustat—Connective tissue disorder—Epirubicin—thyroid cancer	0.00174	0.00351	CcSEcCtD
Miglustat—Visual impairment—Epirubicin—thyroid cancer	0.00171	0.00344	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.00167	0.0272	CbGpPWpGaD
Miglustat—Eye disorder—Epirubicin—thyroid cancer	0.00166	0.00333	CcSEcCtD
Miglustat—Haemoglobin—Doxorubicin—thyroid cancer	0.00165	0.00332	CcSEcCtD
Miglustat—Haemorrhage—Doxorubicin—thyroid cancer	0.00164	0.0033	CcSEcCtD
Miglustat—Hypoaesthesia—Doxorubicin—thyroid cancer	0.00163	0.00328	CcSEcCtD
Miglustat—Connective tissue disorder—Doxorubicin—thyroid cancer	0.00161	0.00324	CcSEcCtD
Miglustat—Chills—Epirubicin—thyroid cancer	0.00159	0.0032	CcSEcCtD
Miglustat—Visual impairment—Doxorubicin—thyroid cancer	0.00158	0.00318	CcSEcCtD
Miglustat—Mental disorder—Epirubicin—thyroid cancer	0.00155	0.00313	CcSEcCtD
Miglustat—Malnutrition—Epirubicin—thyroid cancer	0.00154	0.00311	CcSEcCtD
Miglustat—Eye disorder—Doxorubicin—thyroid cancer	0.00153	0.00308	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.00153	0.0249	CbGpPWpGaD
Miglustat—Flatulence—Epirubicin—thyroid cancer	0.00152	0.00306	CcSEcCtD
Miglustat—Nervousness—Epirubicin—thyroid cancer	0.0015	0.00302	CcSEcCtD
Miglustat—Back pain—Epirubicin—thyroid cancer	0.00149	0.003	CcSEcCtD
Miglustat—Muscle spasms—Epirubicin—thyroid cancer	0.00148	0.00299	CcSEcCtD
Miglustat—Chills—Doxorubicin—thyroid cancer	0.00147	0.00296	CcSEcCtD
Miglustat—Mental disorder—Doxorubicin—thyroid cancer	0.00144	0.00289	CcSEcCtD
Miglustat—Ill-defined disorder—Epirubicin—thyroid cancer	0.00143	0.00288	CcSEcCtD
Miglustat—Malnutrition—Doxorubicin—thyroid cancer	0.00143	0.00287	CcSEcCtD
Miglustat—Flatulence—Doxorubicin—thyroid cancer	0.00141	0.00283	CcSEcCtD
Miglustat—Malaise—Epirubicin—thyroid cancer	0.00139	0.0028	CcSEcCtD
Miglustat—Nervousness—Doxorubicin—thyroid cancer	0.00139	0.00279	CcSEcCtD
Miglustat—Vertigo—Epirubicin—thyroid cancer	0.00139	0.00279	CcSEcCtD
Miglustat—Back pain—Doxorubicin—thyroid cancer	0.00138	0.00278	CcSEcCtD
Miglustat—Muscle spasms—Doxorubicin—thyroid cancer	0.00137	0.00276	CcSEcCtD
Miglustat—Convulsion—Epirubicin—thyroid cancer	0.00134	0.00269	CcSEcCtD
Miglustat—Ill-defined disorder—Doxorubicin—thyroid cancer	0.00133	0.00267	CcSEcCtD
Miglustat—Discomfort—Epirubicin—thyroid cancer	0.0013	0.00261	CcSEcCtD
Miglustat—Malaise—Doxorubicin—thyroid cancer	0.00129	0.00259	CcSEcCtD
Miglustat—Dry mouth—Epirubicin—thyroid cancer	0.00129	0.00259	CcSEcCtD
Miglustat—Vertigo—Doxorubicin—thyroid cancer	0.00128	0.00258	CcSEcCtD
Miglustat—Convulsion—Doxorubicin—thyroid cancer	0.00124	0.00249	CcSEcCtD
Miglustat—Nervous system disorder—Epirubicin—thyroid cancer	0.00124	0.00249	CcSEcCtD
Miglustat—Thrombocytopenia—Epirubicin—thyroid cancer	0.00123	0.00248	CcSEcCtD
Miglustat—Discomfort—Doxorubicin—thyroid cancer	0.0012	0.00242	CcSEcCtD
Miglustat—Anorexia—Epirubicin—thyroid cancer	0.0012	0.00242	CcSEcCtD
Miglustat—Dry mouth—Doxorubicin—thyroid cancer	0.00119	0.00239	CcSEcCtD
Miglustat—GBA2—Metabolism—TPR—thyroid cancer	0.00118	0.0193	CbGpPWpGaD
Miglustat—GBA2—Metabolism—PRKAR1A—thyroid cancer	0.00116	0.019	CbGpPWpGaD
Miglustat—Nervous system disorder—Doxorubicin—thyroid cancer	0.00114	0.0023	CcSEcCtD
Miglustat—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00114	0.0023	CcSEcCtD
Miglustat—Insomnia—Epirubicin—thyroid cancer	0.00114	0.00229	CcSEcCtD
Miglustat—Paraesthesia—Epirubicin—thyroid cancer	0.00113	0.00228	CcSEcCtD
Miglustat—Anorexia—Doxorubicin—thyroid cancer	0.00111	0.00224	CcSEcCtD
Miglustat—Dyspepsia—Epirubicin—thyroid cancer	0.00111	0.00223	CcSEcCtD
Miglustat—Decreased appetite—Epirubicin—thyroid cancer	0.0011	0.0022	CcSEcCtD
Miglustat—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00109	0.00219	CcSEcCtD
Miglustat—Fatigue—Epirubicin—thyroid cancer	0.00109	0.00218	CcSEcCtD
Miglustat—UGCG—Metabolism—TPR—thyroid cancer	0.00108	0.0176	CbGpPWpGaD
Miglustat—Pain—Epirubicin—thyroid cancer	0.00108	0.00217	CcSEcCtD
Miglustat—Constipation—Epirubicin—thyroid cancer	0.00108	0.00217	CcSEcCtD
Miglustat—UGCG—Metabolism—PRKAR1A—thyroid cancer	0.00106	0.0173	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.00105	0.0172	CbGpPWpGaD
Miglustat—Insomnia—Doxorubicin—thyroid cancer	0.00105	0.00212	CcSEcCtD
Miglustat—Paraesthesia—Doxorubicin—thyroid cancer	0.00105	0.00211	CcSEcCtD
Miglustat—Feeling abnormal—Epirubicin—thyroid cancer	0.00104	0.00209	CcSEcCtD
Miglustat—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00103	0.00207	CcSEcCtD
Miglustat—Dyspepsia—Doxorubicin—thyroid cancer	0.00103	0.00206	CcSEcCtD
Miglustat—Decreased appetite—Doxorubicin—thyroid cancer	0.00101	0.00204	CcSEcCtD
Miglustat—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00101	0.00202	CcSEcCtD
Miglustat—Fatigue—Doxorubicin—thyroid cancer	0.00101	0.00202	CcSEcCtD
Miglustat—Pain—Doxorubicin—thyroid cancer	0.000997	0.00201	CcSEcCtD
Miglustat—Constipation—Doxorubicin—thyroid cancer	0.000997	0.00201	CcSEcCtD
Miglustat—Abdominal pain—Epirubicin—thyroid cancer	0.000996	0.002	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.000964	0.0157	CbGpPWpGaD
Miglustat—Feeling abnormal—Doxorubicin—thyroid cancer	0.000961	0.00193	CcSEcCtD
Miglustat—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000953	0.00192	CcSEcCtD
Miglustat—Abdominal pain—Doxorubicin—thyroid cancer	0.000922	0.00185	CcSEcCtD
Miglustat—Asthenia—Epirubicin—thyroid cancer	0.000904	0.00182	CcSEcCtD
Miglustat—GBA2—Metabolism—SLC5A5—thyroid cancer	0.000885	0.0144	CbGpPWpGaD
Miglustat—Diarrhoea—Epirubicin—thyroid cancer	0.000862	0.00173	CcSEcCtD
Miglustat—Asthenia—Doxorubicin—thyroid cancer	0.000836	0.00168	CcSEcCtD
Miglustat—Dizziness—Epirubicin—thyroid cancer	0.000833	0.00168	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	0.000829	0.0135	CbGpPWpGaD
Miglustat—UGCG—Metabolism—SLC5A5—thyroid cancer	0.00081	0.0132	CbGpPWpGaD
Miglustat—Vomiting—Epirubicin—thyroid cancer	0.000801	0.00161	CcSEcCtD
Miglustat—Diarrhoea—Doxorubicin—thyroid cancer	0.000798	0.0016	CcSEcCtD
Miglustat—Headache—Epirubicin—thyroid cancer	0.000789	0.00159	CcSEcCtD
Miglustat—Dizziness—Doxorubicin—thyroid cancer	0.000771	0.00155	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	0.000759	0.0124	CbGpPWpGaD
Miglustat—Nausea—Epirubicin—thyroid cancer	0.000748	0.00151	CcSEcCtD
Miglustat—GBA2—Metabolism—RXRA—thyroid cancer	0.000744	0.0121	CbGpPWpGaD
Miglustat—Vomiting—Doxorubicin—thyroid cancer	0.000741	0.00149	CcSEcCtD
Miglustat—Headache—Doxorubicin—thyroid cancer	0.00073	0.00147	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	0.000723	0.0118	CbGpPWpGaD
Miglustat—Nausea—Doxorubicin—thyroid cancer	0.000692	0.00139	CcSEcCtD
Miglustat—UGCG—Metabolism—RXRA—thyroid cancer	0.00068	0.0111	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	0.000662	0.0108	CbGpPWpGaD
Miglustat—GBA2—Metabolism—PPARG—thyroid cancer	0.00047	0.00766	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PPARG—thyroid cancer	0.00043	0.007	CbGpPWpGaD
Miglustat—GBA2—Metabolism—PTGS2—thyroid cancer	0.000369	0.00602	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PTGS2—thyroid cancer	0.000338	0.00551	CbGpPWpGaD
Miglustat—GBA2—Metabolism—PTEN—thyroid cancer	0.000322	0.00525	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PTEN—thyroid cancer	0.000295	0.0048	CbGpPWpGaD
Miglustat—GBA2—Metabolism—AKT1—thyroid cancer	0.000186	0.00303	CbGpPWpGaD
Miglustat—UGCG—Metabolism—AKT1—thyroid cancer	0.00017	0.00277	CbGpPWpGaD
